AzTrials
AzTrials

Cerebral PalsyNCT06575283

Predicting Cerebral Palsy in Infants With White Matter Injury Using MRI

An observational study of Cerebral Palsy and Periventricular White Matter Abnormalities, run by First Affiliated Hospital Xi'an Jiaotong University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this study is to determin the MRI features associated with cerebral palsy and to develop prediction models of pediatric disorders by combining MRI with artificial intelligence. Read more about this study

Who is it for?
Ages 6 months to 2 yearsHealthy volunteers can take part
How many people
1,000 participants
Where
1 siteChina
Study dates
1 Sep 2024to 31 Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 months to 2 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: This study will follow up infants from multiple regions and different hospitals who underwent MRI examinations between 6 months and 2 years old. Each infant and young child included T1-weighted imaging (T1WI) and T2-weighted imaging (T2WI). According to the follow-up outcomes, these infants will be divided into the following groups: cerebral palsy, other diagnoses that did not develop into cerebral palsy, or inability to confirm the diagnosis.

Who may be able to join

  • Infants and children at high risk of periventricular white matter injury (PVWMI) (gestational age <35 weeks, birth weight <2.6 kg, forceps-assisted delivery/fetal head attraction, Apgar score <7, hypoglycaemia, sepsis, electrolyte disturbances, premature rupture of membranes);
  • Those who underwent MRI at 6 months of age-2 years, including at least T1WI and T2WI sequences;
  • Upon follow-up, the patient's clinical diagnosis: cerebral palsy, other diagnoses that did not develop into cerebral palsy, or inability to confirm the diagnosis).

Who cannot join

  • Incomplete MRI images or unreadable images due to motion artefacts;
  • Incomplete neurobehavioural assessment data (including: gross motor function).

Trial locations and contacts

1 site in 1 country.

Yitong Bian, MD contact

15209220323

bianyt0323@163.com

China1 site
  • The First Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi

    Jian Yang, Ph.D.,M.D., 0086-18991232396, cjr.yangjian@vip.163.com

Other trials in China

About this study

Official title: Early Prediction of Cerebral Palsy by MRI in Infants With White Matter Injury: a Multicenter Study

The goal of this study is to determin the MRI features associated with cerebral palsy and to develop prediction models of pediatric disorders by combining MRI with artificial intelligence.

The main questions it aims to answer are:

  • How to achieve features on conventional MRI associated with cerebral palsy?
  • How to predict the risk of cerebral palsy in infants aged 6 to 2 years based on conventional MRI and deep learning? Researchers will compare characteristics of periventricular white matter injury with cerebral palsy to those without cerebral palsy.

Participants will be asked to provide MRI data, clinical diagnoses information, and follow-up outcomes.

Read the detailed description

Cerebral palsy (CP) is a common group of movement disorders that often results in disability in children. In the context of CP, the importance of early diagnosis is crucial, but current diagnostic modalities often identify cases after the age of 2 years. After initial screening of infants at high risk for CP by behavioral scoring, magnetic resonance imaging (MRI) forms an integral part of the comprehensive evaluation. The training of conventional model of CP risk prediction requires a large investment of time and financial resources. The average sensitivity rate drops to 90%. Up to now, deep learning technology has been widely used in tasks related to image-based disease classification and has shown excellent performance.

Periventricular white matter injury (PVWMI) accounts for the largest proportion of various types of brain injuries in cerebral palsy, and the types of brain injuries in cerebral palsy are rich and complex, posing difficulties and challenges to deep learning models. Therefore, this study focuses on PVWMI, the most common type of cerebral palsy, and uses conventional MRI to develop a deep learning prediction model for CP in infants aged 6 months to 2 years old.

Being tested
No intervention will be performed in this cohort study
Keywords
Cerebral palsy, Periventricular white matter injury, MRI, Deep learning
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No intervention will be performed in this cohort studyOther

    Deep learning classification models will be used for automatic prediction of cerebral palsy. Machines will be used to assist doctors in cerebral palsy risk evaluation.

Study groups in NCT06575283
Study groupRoleWhat they receive
PVWMI Infants aged 6 months to 2 yearsInfants will be scanned by MRI at the age of 6 months to 2 years. The infants of periventricular white matter injury (PVWMI) will be enrolled.
Receives: Other: No intervention will be performed in this cohort study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accuracy of the model predicting cerebral palsy

    Determine the accuracy of PVWMI classification and cerebral palsy prediction. The higher the value, the better the model performance.

    Measured: From September 2024 to December 2025

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Aug 2024
  2. Study start1 Sep 2024 (estimated)
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06575283
Sponsor's protocol ID
XJTU1AF2024LSYY-154
Status last verified
Aug 2024
First submitted
26 Aug 2024
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data will be available from the corresponding author upon reasonable request.

Questions about this trial

What is this clinical trial studying?

An observational study of Cerebral Palsy and Periventricular White Matter Abnormalities, run by First Affiliated Hospital Xi'an Jiaotong University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yitong Bian, MD (15209220323, bianyt0323@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accuracy of the model predicting cerebral palsy (time frame: From September 2024 to December 2025). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in